Video

How Is COVID-19 Impacting The Adoption of Virtual Trials?

Source: Clinical Leader
20_05_CLL_EmbracingVirtualTrials_1920x1080_COVID19

In May 2020 Clinical Leader Live was proud to feature Brian Johnson, Director of Applied Innovation at Otsuka, and Katherine Vandebelt, Global Head of Clinical Innovation for Oracle to discuss whether pharma companies were ready to embrace virtual trials. During the presentation, Johnson and Vandebelt covered several topics, including how COVID-19 has changed the view of virtual trials, whether they will become a future best practice, how Otsuka opted to be a leader in the adoption of virtual technologies, the challenges and benefits of implementing virtual trials, incorporating virtual components into trial protocols, the impact these technologies can have on recruitment and retention, and therapeutic areas where virtual trials might have the biggest impact.

In this video, Vandebelt discusses the impact of COVID-19 on the adoption of virtual trials.

Or click here to see the complete interview.

VIEW THE VIDEO!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: